Souhaitez-vous accéder aux communiqués récents ?

Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.

Se Connecter À Un Compte Lecteur Créer Un Compte Lecteur

15 nov. 2021 07h00 HE | Source: Emergex Vaccines Holding Ltd

Emergex announces approval to initiate Phase I clinical trial of its next generation COVID-19 vaccine candidate

PRESS RELEASE Emergex announces approval to initiate Phase I clinical trial of its next generation COVID-19 vaccine candidate Synthetic vaccine designed to prime T-Cells to rapidly remove...
15 nov. 2021 02h00 HE | Source: Emergex Vaccines Holding Ltd

Emergex announces approval to initiate Phase I clinical trial of its next generation COVID-19 vaccine candidate

PRESS RELEASE Emergex announces approval to initiate Phase I clinical trial of its next generation COVID-19 vaccine candidate Synthetic vaccine designed to prime T-Cells to rapidly remove...